These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4373024)

  • 1. Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.
    Velasco M; O'Malley K; Robie NW; Wells J; Israili ZH; McNay JL
    Clin Pharmacol Ther; 1974 Dec; 16(6):1031-8. PubMed ID: 4373024
    [No Abstract]   [Full Text] [Related]  

  • 2. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.
    O'Malley K; Velasco M; Wells J; McNay JL
    J Clin Invest; 1975 Feb; 55(2):230-5. PubMed ID: 1127099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.
    O'Malley K; Velasco M; Wells J; McNay J
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):355-60. PubMed ID: 971700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
    Pettinger WA; Keeton K
    J Clin Invest; 1975 Feb; 55(2):236-43. PubMed ID: 236325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone system.
    Grim CE; Luft FC; Grim CM; Klotman PE; Van Huysse JW; Weinberger MH
    Arch Intern Med; 1979 May; 139(5):529-33. PubMed ID: 443947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilating antihypertensive drug-induced aldosterone release--a study of endogenous angiotensin-mediated aldosterone release in the rat.
    Campbell WB; Pettinger WA; Keeton K; Brooks SN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):166-75. PubMed ID: 1167223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat.
    Pettinger WA; Campbell WB; Keeton K
    Circ Res; 1973 Jul; 33(1):82-6. PubMed ID: 4765702
    [No Abstract]   [Full Text] [Related]  

  • 8. Clonidine and the vasodilating beta blocker antihypertensive drug interaction.
    Pettinger WA; Mitchell HC; Güllner HG
    Clin Pharmacol Ther; 1977 Aug; 22(2):164-71. PubMed ID: 18312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of minoxidil on blood pressure and hemodynamics in severe hypertension.
    Bryan RK; Hoobler SW; Rosenzweig J; Weller JM; Purdy JM
    Am J Cardiol; 1977 May; 39(6):796-801. PubMed ID: 324257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ro 42-5892 is a potent orally active renin inhibitor in primates.
    Fischli W; Clozel JP; el Amrani K; Wostl W; Neidhart W; Stadler H; Branca Q
    Hypertension; 1991 Jul; 18(1):22-31. PubMed ID: 1830563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
    Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G
    J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension.
    Werning C
    Klin Wochenschr; 1976 Aug; 54(15):727-34. PubMed ID: 790007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole body and regional hemodynamic effects of minoxidil in the conscious dog.
    Humphrey SJ; Zins GR
    J Cardiovasc Pharmacol; 1984; 6(6):979-88. PubMed ID: 6084789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive and renin angiotensin effects of metolazone with and without propranolol.
    Sambhi MP; Eggena P; Barrett JD; Thananopavarn C; Tuck M; Wiedman C
    J Clin Pharmacol; 1977 Apr; 17(4):214-24. PubMed ID: 849995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.
    Bianchetti MG; Weidmann P; Boehringer K; Link L; Schiffl H; Beretta-Piccoli C; Colombo JP
    Eur J Clin Pharmacol; 1982; 23(6):483-9. PubMed ID: 7160416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of renin release by combining renal arterial constriction and beta-adrenergic stimulation.
    Eide I; Löyning E; Kill F
    Scand J Clin Lab Invest; 1974 Dec; 34(4):301-10. PubMed ID: 4460225
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased aldosterone metabolic clearance in hypertensive patients treated with minoxidil: an effect of greater hepatic perfusion.
    Pratt JH; Yager CJ; Grim CE; Parkinson CA
    J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S236-41. PubMed ID: 6156360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol of vascular responses to sympathetic nerve stimulation and plasma renin activity in mongrel dogs.
    Lokhandwala MF; Asaad M; Buckley JP
    Eur J Pharmacol; 1976 Jul; 38(1):141-7. PubMed ID: 8318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.